维生素中国E-新闻(维生素中国电子新闻202301)

In Jan., 2023, the vitamin market in China was languishing. As Spring Festival was approaching, there were only few downstream purchasers who placed orders for restocking. Upstream vitamin producers were mostly unwilling to lower the prices. In mid-Jan., even the purchases with the aim of restocking stopped; distributors were pressurised by inventory and lack of funds into actively trying to strike deals. The prices of most vitamins declined in Jan. Vitamin B12 and vitamin C received much market attention.

After an expedited review was conducted by NMPA, 13 symptomatic treatment drugs for COVID-19 infection were approved. One of those 13 drugs, "Paracetamol and Vitamin C Effervescent Tablets" is from Hainan Taosheng Medical Technology Research Institute Co., Ltd. The production capacity for this product in the market may be further expanded and relevant pharmaceutical enterprises could find more opportunities of development amidst competition.

News about several projects has been reported, including: Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.'s "construction project of pyrroloquinoline quinone (PQQ) and other products", Anhui Xinhong Pharmaceutical Co., Ltd.'s folic acid reconstruction and expansion project, Guangxi Entai Pharmaceutical Co., Ltd.'s pharmaceutical intermediates and nutritional supplements project, Heilongjiang Jiqin Pharmaceutical Co., Ltd.'s special active pharmaceutical ingredients (API) and high-end preparations project, Xinfa Pharmaceutical Co., Ltd.'s "vitamin B2 retrofitting (by introducing intelligent technologies) project", and Hubei Guangji Pharmaceutical Co., Ltd.'s "1,000 t/a (1%) vitamin B12 comprehensive utilisation project".

India has initiated an anti-dumping investigation into the vitamin A palmitate products that originate in or are imported from China. Currently, Chinese vitamin A is mainly exported to Europe and North America. India is not a major export destination of Chinese VA, as the volume of China's VA exports to India merely takes up a small percentage of China's total export volume of VA. A market insider estimates that India's anti-dumping investigation will only impose a limited impact on China's VA exports.

The USD/RMB exchange rate in this Report is USD1.00=CNY6.9475 on 3 Jan., 2023, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.